Regenerative medicine – cell therapies

Regenerative Medicine is the process of creating living, functional tissues to repair or replace tissue or organ function lost due to age, disease, damage, or congenital defects.

This field holds the promise of regenerating damaged tissues and organs in the body by stimulating previously irreparable organs to heal themselves. Regenerative medicine also empowers scientists to grow tissues and organs in the laboratory and safely implant them when the body cannot heal itself.

Cell technologies – Medicine of 21st century

“All diseases begin at cell level” proclaimed the famous German scientist Rudolf Virchov in the 19th. Century.

The 21st. Century is a century of biomedicine, cell biology and molecular medicine. It is a century of cells.

Pluripotent stem cells offer the possibility of a renewable source of replacement cells and tissues to treat a myriad of diseases, conditions, and disabilities including Parkinson”s a disease and Alzheimer”s disease, spinal cord injury, stroke, burns, heart disease, diabetes, osteoarthritis and rheumatoid arthritis.

Stem cell research offers enormous potential for major advances in clinical therapy. Stem cells could be used to replace missing or damaged cells in important diseases. Today, donated organs and tissues are often used to replace those that are diseased or destroyed. Unfortunately, the number of people needing a transplant far exceeds the number of organs available for transplantation.

The healing potential of stem cells

Another potential application of stem cells is making cells and tissues for medical therapies. Today, donated organs and tissues are often used to replace those that are diseased or destroyed. Unfortunately, the number of people needing a transplant far exceeds the number of organs available for transplantation.

Pluripotent stem cells offer the possibility of a renewable source of replacement cells and tissues to treat a myriad of diseases, conditions, and disabilities the total number for today is approximately 150.

The risks associated with autologous tissues repair cells therapy are low. They are no different from the risks normally associated with surgical procedures. The entire procedure is performed in compliance with the principles of “Good Manufacturing Practice” and in accordance with the latest technological and medical standards.

The therapy involves the use of the patient’s own cells, so the risk of rejection – as there would be in a cell or organ transplant procedure – is almost nil.